Caxton Corporation’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Caxton Corporation’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,333	Closed	-$17K	–	21
2022 Q3	$17K	Hold	21,333	–	–	0.03%	14
2022 Q2	$2K	Hold	21,333	–	–	﹤0.01%	16
2022 Q1	$4K	Hold	21,333	–	–	0.01%	37
2021 Q4	$12K	Hold	21,333	–	–	0.01%	51
2021 Q3	$14K	Hold	21,333	–	–	0.01%	54
2021 Q2	$26K	Hold	21,333	–	–	0.02%	62
2021 Q1	$19K	Buy	+21,333	New	+$36.1K	0.01%	68

Caxton Corporation's FLACW Position: Q4 2022 in Review

Caxton Corporation sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 21,333 shares — an estimated $17K sold.

Caxton Corporation first reported a position in FLACW in Q1 2021 and held it in 7 quarters. The position peaked at $26K in Q2 2021. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Caxton Corporation reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Caxton Corporation sold 21,333 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $17K.
Caxton Corporation first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 7 quarters.
Caxton Corporation's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $26K in Q2 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Caxton Corporation's 13F filing for Q4 2022, filed 14 Feb 2023.